Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaclyn F Hechtman

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Molecular Cancer Research : MCR|December 15, 2015
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAFJaclyn F Hechtman, Ahmet Zehir, Rona Yaeger, et al.
Cancer Discovery|June 18, 2020
Lineage Reversion Drives WNT Independence in Intestinal CancerTeng Han, Sukanya Goswami, Yang Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2020
A Performance Comparison of Commonly Used Assays to Detect RET FusionsSoo-Ryum Yang, Umut Aypar, Ezra Y Rosen, et al.
JCO Precision Oncology|September 14, 2020
Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab EmtansineSebastian Mondaca, Pedram Razavi, Chongrui Xu, et al.
Clinical Colorectal Cancer|October 15, 2018
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell CancerSebastian Mondaca, Walid K Chatila, David Bates, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 4, 2019
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfallsJames P Solomon, Irina Linkov, Andrea Rosado, et al.
The Journal of Molecular Diagnostics : JMD|December 29, 2016
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling AssayDara S Ross, Ahmet Zehir, Donavan T Cheng, et al.
JCO Precision Oncology|April 23, 2019
Majority of <i>B2M</i>-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-HighSumit Middha, Rona Yaeger, Jinru Shia, et al.
Molecular Cancer Research : MCR|February 11, 2017
Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall SurvivalRyan N Ptashkin, Carlos Pagan, Rona Yaeger, et al.
JCO Precision Oncology|September 14, 2018
Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing DataSumit Middha, Liying Zhang, Khedoudja Nafa, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Molecular Cancer Research : MCR|December 15, 2015
Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAFJaclyn F Hechtman, Ahmet Zehir, Rona Yaeger, et al.
Cancer Discovery|June 18, 2020
Lineage Reversion Drives WNT Independence in Intestinal CancerTeng Han, Sukanya Goswami, Yang Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2020
A Performance Comparison of Commonly Used Assays to Detect RET FusionsSoo-Ryum Yang, Umut Aypar, Ezra Y Rosen, et al.
JCO Precision Oncology|September 14, 2020
Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab EmtansineSebastian Mondaca, Pedram Razavi, Chongrui Xu, et al.
Clinical Colorectal Cancer|October 15, 2018
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell CancerSebastian Mondaca, Walid K Chatila, David Bates, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 4, 2019
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfallsJames P Solomon, Irina Linkov, Andrea Rosado, et al.
The Journal of Molecular Diagnostics : JMD|December 29, 2016
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling AssayDara S Ross, Ahmet Zehir, Donavan T Cheng, et al.
JCO Precision Oncology|April 23, 2019
Majority of <i>B2M</i>-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-HighSumit Middha, Rona Yaeger, Jinru Shia, et al.
Molecular Cancer Research : MCR|February 11, 2017
Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall SurvivalRyan N Ptashkin, Carlos Pagan, Rona Yaeger, et al.
JCO Precision Oncology|September 14, 2018
Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing DataSumit Middha, Liying Zhang, Khedoudja Nafa, et al.
Pageof 12